시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 크립토코쿡스증 시장 보고서(2025년)
Cryptococcosis Global Market Report 2025
상품코드 : 1730821
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 크립토코쿡스증 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측기간의 성장은 인체 면역결핍 바이러스(HIV) 및 후천성 면역결핍 증후군(AIDS)과 면역억제성 질환의 유병률 상승, 신규 항진균요법 채용 증가, 항진균제 연구개발 투자 증가, 개발도상지역에서의 의료 접근 확대, 항진균제 병용요법 출현, 감염증 대책에 대한 정부의 이니셔티브 증가, 크립토코쿡스 감염에 대한 의식이 높아지기 때문이라고 생각됩니다.

호흡기 감염 증가는 크립토코쿡스증 시장의 성장을 가속할 것으로 예측됩니다. 코, 목, 기도 및 폐를 포함한 호흡기 시스템에 영향을 미치는 호흡기 감염은 바이러스, 박테리아 및 곰팡이에 의해 발생할 수 있습니다. 대기 오염은 호흡기 감염 증가에 기여합니다. 연기, 먼지, 화학물질 등의 유해한 오염물질이 폐기능에 손상을 주고 개인이 병에 걸리기 쉬워지기 때문입니다. 면역력이 저하되면 크립토코쿡스증과 같은 기회감염이 발병하기 쉬운 조건이 갖춰집니다. 주로 폐와 중추 신경계를 침범하는이 곰팡이 감염은 면역력이 떨어진 사람에게 심각한 위험을 초래합니다. 예를 들어, 2024년 12월 호주 통계국은 인플루엔자와 관련된 사망자 수 증가를 보고했으며, 2022년 427명에 대해 2024년 951명이 사망했습니다. 그 결과 호흡기 감염의 이환율 증가가 크립토코쿡스증 시장의 성장을 가속하고 있습니다.

또한, 인간 면역결핍 바이러스(HIV)의 만연도 크립토코쿡스증 시장의 성장을 가속할 것으로 예측되고 있습니다. HIV는 면역계를 공격하고 특히 CD4 세포를 표적화하기 때문에 신체가 감염과 질병에 걸리기 쉽습니다. HIV 감염자 증가는 감염과 예방에 대한 인식과 교육의 부족이 위험한 행동, 진단 지연, 바이러스의 의도하지 않은 확산의 고율로 이어지고 있기 때문입니다. HIV에 감염되면 면역력이 저하되어 크립토코쿡스증을 포함한 기회감염에 걸리기 쉬워집니다. HIV 감염자 수가 증가함에 따라 크립토코쿡스 감염의 위험도 증가하여 효과적인 치료에 대한 수요가 증가하고 시장 성장이 촉진됩니다. 예를 들어 2024년 10월 영국 보건보장청은 2023년 HIV 진단이 51% 증가했으며 2022년 3,975건에 비해 6,008건의 신규 사례가 발생했다고 보고했습니다. 따라서 HIV의 유병률 증가는 크립토코쿡스증 시장의 성장에 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Cryptococcosis is a fungal infection caused by species of Cryptococcus, such as Cryptococcus neoformans and Cryptococcus gattii, which primarily affect the lungs and central nervous system (CNS). It primarily occurs in immunocompromised individuals, including those with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), organ transplant recipients, and patients undergoing immunosuppressive therapy. If untreated, this infection can lead to cryptococcal meningitis, a life-threatening condition.

The main treatment options for cryptococcosis include adjunctive therapies and antifungal drugs. Adjunctive therapies are additional treatments used alongside primary therapy to enhance effectiveness, improve patient outcomes, or manage side effects. Diagnostic techniques for cryptococcosis include culture methods, microscopic examination, and molecular techniques, which are used to diagnose various infections, including cerebral and pulmonary cryptococcosis. The primary end users of these treatments include clinics, home healthcare providers, hospitals, and research institutes.

The cryptococcosis market research report is one of a series of new reports from The Business Research Company that provides cryptococcosis market statistics, including cryptococcosis industry global market size, regional shares, competitors with a cryptococcosis market share, detailed cryptococcosis market segments, market trends and opportunities, and any further data you may need to thrive in the cryptococcosis industry. This cryptococcosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cryptococcosis market size has grown strongly in recent years. It will grow from $6.52 billion in 2024 to $7.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the rising incidence of immunosuppressive conditions, advancements in antifungal therapies, an increase in organ transplant procedures, greater awareness of fungal infections, the development of amphotericin B formulations, the emergence of Cryptococcus gattii outbreaks, the expansion of healthcare infrastructure, and regulatory approvals for antifungal drugs.

The cryptococcosis market size is expected to see strong growth in the next few years. It will grow to $10.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth during the forecast period can be attributed to the rising prevalence of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and immunosuppressive diseases, the increasing adoption of novel antifungal therapies, growing investments in research and development for antifungal drugs, the expansion of healthcare access in developing regions, the emergence of combination antifungal therapies, rising government initiatives for infectious disease control, and increasing awareness of cryptococcal infections. Major trends during this period include the development of next-generation antifungal drugs, AI-driven predictive analytics for infection outbreaks, nanotechnology-based drug delivery systems, wearable biosensors for early detection, blockchain for secure pharmaceutical supply chains, 3D bioprinting for fungal infection modeling, machine learning in antifungal drug discovery, and advancements in immunotherapy for cryptococcosis treatment.

The increasing occurrence of respiratory infections is expected to drive the growth of the cryptococcosis market. Respiratory infections, which impact the respiratory system including the nose, throat, airways, and lungs, can be caused by viruses, bacteria, or fungi. Air pollution is contributing to the rise in respiratory infections, as harmful pollutants such as smoke, dust, and chemicals damage lung function, making individuals more susceptible to diseases. A weakened immune system creates favorable conditions for opportunistic infections such as cryptococcosis to develop. This fungal infection, which primarily affects the lungs and central nervous system, poses significant risks for immunocompromised individuals. For example, in December 2024, the Australian Bureau of Statistics reported an increase in influenza-related deaths, with 951 deaths in 2024 compared to 427 in 2022. As a result, the growing incidence of respiratory infections is fueling the growth of the cryptococcosis market.

The increasing prevalence of human immunodeficiency virus (HIV) is also expected to drive the cryptococcosis market forward. HIV attacks the immune system, particularly targeting CD4 cells, making the body more vulnerable to infections and diseases. The rise in HIV cases is attributed to a lack of awareness and education regarding transmission and prevention, leading to risky behaviors, delayed diagnoses, and a higher rate of unintentional spread of the virus. As HIV weakens the immune system, individuals become more susceptible to opportunistic infections, including cryptococcosis. With the number of HIV cases increasing, the risk of cryptococcal infections rises, leading to greater demand for effective treatments and driving market growth. For instance, in October 2024, the UK Health Security Agency reported that HIV diagnoses increased by 51% in 2023, with 6,008 new cases compared to 3,975 in 2022. Therefore, the rising prevalence of HIV is contributing to the growth of the cryptococcosis market.

Leading companies in the cryptococcosis market are actively conducting clinical trials to improve the safety and effectiveness of antifungal treatments. These trials play a crucial role in assessing new therapies and enhancing treatment outcomes for patients suffering from severe fungal infections. For example, in August 2023, Matinas BioPharma Holdings Inc., a clinical-stage biopharmaceutical company based in the United States, reported promising results from its Phase II EnACT trial, which tested MAT2203 for the treatment of cryptococcal meningitis. MAT2203 is an oral lipid nanocrystal formulation of amphotericin B that targets fungal cell membranes, causing cell death. The trial demonstrated better survival rates among patients and a favorable safety profile, suggesting that MAT2203 could be a groundbreaking treatment for cryptococcosis, including cryptococcal meningitis.

Major players in the cryptococcosis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbott Laboratories, Gilead Sciences Inc., Asahi Kasei Pharma Corporation, Viatris Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories, Century Pharmaceuticals Ltd., Beijing Lunarsun Pharmaceutical Co. Ltd., PharmaCompass, Matinas Biopharma Holdings Inc., LGM Pharma, Atom Pharma, Brundavan Laboratories Pvt. Ltd., Zeon Health Industries, and Amar Healthcare.

North America was the largest region in the cryptococcosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cryptococcosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cryptococcosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cryptococcosis market consists of revenues earned by entities by providing services such as diagnostic testing, antifungal treatment, hospital care, disease management, telemedicine consultations, research and development, clinical trials, patient monitoring, and epidemiological surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cryptococcosis market also includes sales of amphotericin B, flucytosine, fluconazole, and voriconazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cryptococcosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cryptococcosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cryptococcosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cryptococcosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cryptococcosis Market Characteristics

3. Cryptococcosis Market Trends And Strategies

4. Cryptococcosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cryptococcosis Growth Analysis And Strategic Analysis Framework

6. Cryptococcosis Market Segmentation

7. Cryptococcosis Market Regional And Country Analysis

8. Asia-Pacific Cryptococcosis Market

9. China Cryptococcosis Market

10. India Cryptococcosis Market

11. Japan Cryptococcosis Market

12. Australia Cryptococcosis Market

13. Indonesia Cryptococcosis Market

14. South Korea Cryptococcosis Market

15. Western Europe Cryptococcosis Market

16. UK Cryptococcosis Market

17. Germany Cryptococcosis Market

18. France Cryptococcosis Market

19. Italy Cryptococcosis Market

20. Spain Cryptococcosis Market

21. Eastern Europe Cryptococcosis Market

22. Russia Cryptococcosis Market

23. North America Cryptococcosis Market

24. USA Cryptococcosis Market

25. Canada Cryptococcosis Market

26. South America Cryptococcosis Market

27. Brazil Cryptococcosis Market

28. Middle East Cryptococcosis Market

29. Africa Cryptococcosis Market

30. Cryptococcosis Market Competitive Landscape And Company Profiles

31. Cryptococcosis Market Other Major And Innovative Companies

32. Global Cryptococcosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cryptococcosis Market

34. Recent Developments In The Cryptococcosis Market

35. Cryptococcosis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기